Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2017

Published : Jun-2017

No. of Pages : 119

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Metered Dose Inhaler Devices Overview 6
3 Products under Development 7
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 7
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory 8
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 9
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date 10
3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials 11
4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies 12
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development 12
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 13
5 Metered Dose Inhaler Devices Companies and Product Overview 14
5.1 Aerophase Inc Company Overview 14
5.1.1 Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Circassia Pharmaceuticals Plc Company Overview 15
5.2.1 Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Globe Medical Tech Inc Company Overview 19
5.3.1 Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Lab Automate Technologies Inc Company Overview 20
5.4.1 Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Medicom Innovation Partner a/s Company Overview 21
5.5.1 Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 Min USA LLC Company Overview 22
5.6.1 Min USA LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Mylan NV Company Overview 23
5.7.1 Mylan NV Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Propeller Health Company Overview 24
5.8.1 Propeller Health Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 Rensselaer Polytechnic Institute Company Overview 25
5.9.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 Vectura Group Plc Company Overview 26
5.10.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 Verona Pharma Plc Company Overview 28
5.11.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 28
6 Metered Dose Inhaler Devices- Recent Developments 29
6.1 May 17, 2017: Teva Showcases Asthma Research at the 2017 American Thoracic Society International Conference 29
6.2 May 10, 2017: Mylan Reports First Quarter 2017 Results 30
6.3 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy 32
6.4 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 32
6.5 May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 34
6.6 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued 35
6.7 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 39
6.8 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 40
6.9 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 40
6.10 Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 41
6.11 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 42
6.12 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 43
6.13 Mar 06, 2017: Vectura Group: Board Change 44
6.14 Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 45
6.15 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting 47
6.16 Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products 48
6.17 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 49
6.18 Jan 26, 2017: Symbicort granted paediatric exclusivity in the US 51
6.19 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report 51
6.20 Jan 26, 2017: Achievement of sales milestone for COPD products 52
6.21 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback 53
6.22 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 60
6.23 Jan 11, 2017: Vectura Group: Pre-close update 60
6.24 Dec 21, 2016: Symbicort Maintenance And Reliever Therapy (SMART) now available for adolescents in the UK offering patient-adjusted asthma treatment 61
6.25 Dec 14, 2016: Consort Medical: Directorate Change 63
6.26 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 63
6.27 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 65
6.28 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda 66
6.29 Nov 25, 2016: Consort Medical: CFO Appointment 67
6.30 Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 67
6.31 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters 72
6.32 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 79
6.33 Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 82
6.34 Aug 17, 2016: Consort Medical Announces Directorate Change 82
6.35 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 83
6.36 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses 86
6.37 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 88
6.38 Jul 08, 2016: Dr John Brown, Non-Executive Director, confirms date to step down 94
6.39 Jul 04, 2016: Marco Filippini Appointed Vice Coordinator of the Italian Biosimilars Group 94
6.40 Jun 16, 2016: Consort Medical Announces Final results For The Year Ended 30 April 2016 95
6.41 Jun 10, 2016: Vectura Group announces Directorate Changes 104
6.42 Jun 10, 2016: Simone Menne - new Member of the Board of Managing Directors of Boehringer Ingelheim/Responsible for Corporate Board Division Finance 104
6.43 Jun 08, 2016: Merck Expands its Investment Fund Merck Ventures 105
6.44 May 26, 2016: Vectura Group - Preliminary Results for twelve months ending 31 March 2016 105
6.45 May 25, 2016: Novartis highlights its strong foundation for long-term, sustainable growth at the third Meet Novartis Management event 113
6.46 May 24, 2016: COTA Increases Cross-Industry Support With the Addition of Celgene, Foundation Medicine HealthScape Advisors and Novartis as Strategic Investors 114
7 Appendix 116
7.1 Methodology 116
7.2 About GlobalData 119
7.3 Contact Us 119
7.4 Disclaimer 119

1.1 List of Tables
Table 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 7
Table 2: Metered Dose Inhaler Devices - Pipeline Products by Territory 8
Table 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 9

1.2 List of Figures
Figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 7
Figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory 8
Figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 9
Figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date 10
Figure 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials 11

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027